CSL - Rentabilidad Por Dividendo

Precio De Mercado
139.19
Cambio Diario
-1.04 -0.74%
Mensual
-2.38%
Anual
-40.28%
Q2 Expectativa
136.36




Dy Cambio Fecha
Alterity Therapeutics Limited AUD 0 0 2024-12
Arca Biopharma 0 0 2025-03
Bio Path 0 0 2025-03
Brainstorm Cell Therapeutics 0 0 2025-03
Cara Therapeutics 0 0 2025-03
CSL USD 2.53 0.78 2025-12
Esperion Therapeutics 0 0 2025-03
Infinity Pharmaceuticals 0 0 2023-06
Minerva Neurosciences 0 0 2025-03
Sangamo BioSciences 0 0 2025-03
TherapeuticsMD 0 0 2025-03